Skip to main content
. 2020 Jul 27;24:461. doi: 10.1186/s13054-020-03147-3

Fig. 2.

Fig. 2

OPLS-DA analysis of DI-MS/MS day 1 plasma metabolites comparing non-survivors (n = 75) to survivors (n = 75) of bacterial CAP patients. This shows a predictable model with a high statistical significance using VIP > 1.0 including 20 metabolites (R2Y = 0.331, Q2Y = 0.299, p = 1.15 × 10−8)